Thrombosis Drug Market

15 Jun


Thrombosis Drug Market Poised to Grow at a CAGR of 9.1% by 2024

  • By admin

  • February, 2019

Infinium Global Research has added a new report on the Thrombosis Drug Market. The report presents an analysis of global as well as regional markets of thrombosis drug market over the period of 2016 to 2024. Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global thrombosis drug market but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2016 and estimated for the forecast period of 2018-2024.


Get 15% discount for early purchase of global thrombosis drug market report by clicking the following link, Use code IGRD15 to request the discount in the given form


The recent report identified that North America dominated the global thrombosis drug market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the thrombosis drug market worldwide.


The report segments the global thrombosis drug market on the basis of drug class, disease type, and distribution channel.


Global Thrombosis Drug Market by Drug Class

·         P2Y12 Platelet Inhibitor

·         Factor Xa Inhibitor

·         Heparin


Global Thrombosis Drug Market by Disease Type

·         Deep Vein Thrombosis

·         Pulmonary Embolism

·         Atrial Fibrillation


Global Thrombosis Drug Market by Distribution Channel

·         Online Pharmacies

·         Hospital Pharmacies

·         Retail Pharmacies


Companies Profiled in the Report

·         AstraZeneca PLC

·         Boehringer Ingelheim GmbH

·         Johnson & Johnson

·         Sanofi

·         Aspen Pharmacare Holdings Limited

·         Bayer AG

·         Bristol-Myers Squibb

·         Pfizer, Inc

·         Baxter International, Inc.

·         GlaxoSmithKline plc.


About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which is blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.